항체 전문 신약 개발 회사, 신규한 신생혈관생성인자 타깃, 노벨티노빌리티
Investors 2
| Date | Name | Website |
| - | JX Partner... | jxpartners... |
| - | Neoplux | shinhanvc.... |
Mentions in press and media 2
| Date | Title | Description |
| 28.10.2024 | GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies | YONGIN, South Korea, Oct. 28, 2024 /PRNewswire/ -- GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeutics, for the joint research and de... |
| - | Novelty Nobility | “자체 발굴한 목적 지향적(fit-for-purpose) 항체를 바탕으로 혁신 신약을 개발하는 바이오텍 노벨티노빌리티” |